EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10

Medical Devices Regulation - Hazardous Substances

EU. Hazardous Substances for Purposes of Medical Devices Regulation 2017/745/EU, 5 May 2017, as amended by Regulation 2020/561/EU, 24 April 2020

This list contains hazardous substances for purposes of the Medical Devices Regulation (MDR), based on the legislation's Annex I general safety and performance requirements, including for chemical, physical and biological properties. Specifically, the non-exhaustive database is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list).

RELEVANT LEGISLATION
Last updated 26 srpnja 2024. Database contains 4917 unique substances/entries.
Filter the list

Stranica 95 od 99
50 Broj stavki po stranici
Prikaz 4.701 - 4.750 od 4.917 rezultata.
Substance Name
EC No.
CAS No.
EU CLP (1272/2008)
EU REACH: List of SVHC
EU_BA Directive 2000/54/EC
 
3-(difluoromethyl)-1-methyl-N-(3',4',5'-trifluorobiphenyl-2-yl)pyrazole-4-carboxamide; fluxapyroxad
620-041-3
907204-31-3
Lact.
Details
3-bromo-2,2-bis(bromomethyl)propan1-ol
622-370-8
1522-92-5
Carc. 1B; Muta. 2
C Carcinogenic (article 57a)
Details
4-(1,1,3,3-Tetramethylbutyl)phenol, ethoxylated
621-341-7
2315-61-9
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
4-(2,6-dimethylheptan-2-yl)phenol
635-388-6
521947-27-3
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
4-(3,5-dimethylheptan-3-yl)phenol
635-389-1
186825-36-5
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
4-(3,6-dimethylheptan-3-yl)phenol
635-391-2
142731-63-3
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
4-(3-ethylheptan-2-yl)phenol
635-696-0
186825-39-8
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
4-Isododecylphenol;Phenol, 4-isododecyl
608-055-8
27147-75-7;27459-10-5
R Toxic for reproduction (article 57c)
ENDE Endocrine disrupting properties (Article 57(f) - environment)
END Endocrine disrupting properties (Article 57(f) - human health)
Details
4-Isododecylphenol;Phenol, 4-isododecyl
608-055-8
27147-75-7;27459-10-5
R Toxic for reproduction (article 57c)
ENDE Endocrine disrupting properties (Article 57(f) - environment)
END Endocrine disrupting properties (Article 57(f) - human health)
Details
4-nitrosomorpholine
627-564-6
59-89-2
Carc. 1B; Muta. 2; STOT RE 1
Details
4-tert-Octylphenol monoethoxylate
621-345-9
2315-67-5
ENDE Endocrine disrupting properties (Article 57(f) - environment)
Details
5-fluoro-1,3-dimethyl-N-[2-(4-methylpentan-2-yl)phenyl]-1H-pyrazole-4-carboxamide; 2'-[(RS)-1,3-dimethylbutyl]-5-fluoro-1,3-dimethylpyrazole-4-carboxanilide; penflufen
619-823-7
494793-67-8
Carc. 2
Details
8,9-dinorborn-5-ene-2,3-dicarboxylic anhydride
620-411-4
123748-85-6
Acute Tox. 4; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1
Details
abamectin (combination of avermectin B1a and avermectin B1b) (ISO)
615-339-5
71751-41-2
Repr. 2; Acute Tox. 2; Acute Tox. 1; STOT RE 1
Details
acequinocyl (ISO); 3-dodecyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl acetate
611-595-7
57960-19-7
Skin Sens. 1; STOT SE 1; STOT RE 2
Details
acetamiprid (ISO); (1E)-N-[(6-chloropyridin-3-yl)methyl]-N'-cyano-N-methylethanimidamide; (E)-N1-[(6-chloro-3-pyridyl)methyl]-N2-cyano-N1-methylacetamidine
603-921-1
135410-20-7
Repr. 2; Acute Tox. 3
Details
acetamiprid (ISO); (1E)-N-[(6-chloropyridin-3-yl)methyl]-N’-cyano-N-methylethanimidamide; (E)-N1-[(6-chloro-3-pyridyl)methyl]-N2-cyano-N1-methylacetamidine
682-791-8
160430-64-8
Repr. 2; Acute Tox. 3
Details
Alpha-hexabromocyclododecane
603-801-9
134237-50-6
PBT Persistent, Bioaccumulative and Toxic (article 57d)
Details
Aluminosilicate Refractory Ceramic Fibres
604-314-4
142844-00-6
C Carcinogenic (article 57a)
Details
amisulbrom (ISO); 3-(3-bromo-6-fluoro-2-methylindol-1-ylsulfonyl)-N,N-dimethyl-1H-1,2,4-triazole-1-sulfonamide
672-776-4
348635-87-0
Carc. 2; Eye Irrit. 2
Details
Asbestos, actinolite
616-471-6
77536-66-4
Carc. 1A; STOT RE 1
Details
Asbestos, anthophyllite
616-472-1
77536-67-5
Carc. 1A; STOT RE 1
Details
Asbestos, grunerite
601-801-3
12172-73-5
Carc. 1A; STOT RE 1
Details
Asbestos, tremolite
616-473-7
77536-68-6
Carc. 1A; STOT RE 1
Details
azafenidin (ISO); 2-(2,4-dichloro-5-prop-2-ynyloxyphenyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyridine-3(2H)-one
620-425-0
68049-83-2
Repr. 1B; STOT RE 2
Details
azoxystrobin (ISO); methyl (E)-2-{2-[6-(2-cyanophenoxy)pyrimidin-4-yloxy]phenyl}-3-methoxyacrylate
603-524-3
131860-33-8
Acute Tox. 3
Details
basic phenylmercury nitrate
620-403-0
8003-05-2
Acute Tox. 3; STOT RE 1; Skin Corr. 1B
Details
benfuracarb (ISO); ethyl N-[2,3-dihydro-2,2-dimethylbenzofuran-7-yloxycarbonyl(methyl)aminothio]-N-isopropyl-β-alaninate
617-356-3
82560-54-1
Repr. 2; Acute Tox. 3; Acute Tox. 4
Details
bensultap (ISO); 1,3-bis(phenylsulfonylthio)-2-(N,N-dimethylamino)propane
605-769-1
17606-31-4
Acute Tox. 4
Details
benzovindiflupyr (ISO); N-[9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide
691-719-4
1072957-71-1
Acute Tox. 3
Details
Beta-hexabromocyclododecane
603-802-4
134237-51-7
PBT Persistent, Bioaccumulative and Toxic (article 57d)
Details
bifenthrin (ISO); (2-methylbiphenyl-3-yl)methylrel-(1R,3R)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethylcyclopropanecarboxylate
617-373-6
82657-04-3
Carc. 2; Acute Tox. 3; Acute Tox. 2; STOT RE 1; Skin Sens. 1B
Details
bis(N-hydroxy-N-nitrosocyclohexylaminato-O,O')copper; bis(N-cyclohexyl-diazenium-dioxy)-copper; [Cu-HDO]
608-595-4
312600-89-8
Flam. Sol. 1; Acute Tox. 4; STOT RE 2; Eye Dam. 1
Details
bordeaux mixture; reaction products of copper sulphate with calcium dihydroxide
616-932-1
8011-63-0
Acute Tox. 4; Eye Dam. 1
Details
bufencarb (ISO); reaction mass of 3-(1-methylbutyl)phenyl N-methylcarbamate and 3-(1-ethylpropyl)phenyl N-methylcarbamate
620-359-2
8065-36-9
Acute Tox. 3
Details
Cadmium chloride, hydrate (2:5)
640-998-0
7790-78-5
C Carcinogenic (article 57a)
M Mutagen (article 57b)
R Toxic for reproduction (article 57c)
HH2 Specific target organ toxicity after repeated exposure (Article 57(f) - human health)
Details
cellulose nitrate; nitrocellulose
618-392-2
9004-70-0
Expl. 1.1
Details
chlorfenapyr (ISO); 4-bromo-2-(4-chlorophenyl)-1-ethoxymethyl-5-trifluoromethylpyrrole-3-carbonitrile
602-782-4
122453-73-0
Acute Tox. 3; Acute Tox. 4
Details
cinidon ethyl (ISO); ethyl (Z)-2-chloro-3-[2-chloro-5-(cyclohex-1-ene-1,2-dicarboximido)phenyl]acrylate
604-318-6
142891-20-1
Carc. 2; Skin Sens. 1
Details
clethodim (ISO); (5RS)-2-{(1EZ)-1-[(2E)-3-chloroallyloxyimino]propyl}-5-[(2RS)-2-(ethylthio)propyl]-3-hydroxycyclohex-2-en-1-one
619-396-7
99129-21-2
Acute Tox. 4; Skin Sens. 1
Details
clodinafop-propargyl (ISO)
600-662-6
105512-06-9
Acute Tox. 4; STOT RE 2; Skin Sens. 1
Details
clomazone (ISO); 2-(2-chlorobenzyl)-4,4-dimethyl-1,2-oxazolidin-3-one
617-258-0
81777-89-1
Acute Tox. 4
Details
cobalt nickel oxide
620-395-9
12737-30-3
Carc. 1A; STOT RE 1; Skin Sens. 1
Details
copper sulphate pentahydrate
616-477-9
7758-99-8
Acute Tox. 4; Eye Dam. 1
Details
cyanofenphos (ISO); O-4-cyanophenyl O-ethyl phenylphosphonothioate
620-377-0
13067-93-1
Acute Tox. 3; STOT SE 1; Acute Tox. 4; Eye Irrit. 2
Details
cyflumetofen (ISO); 2-methoxyethyl (RS)-2-(4-tert-butylphenyl)-2-cyano-3-oxo-3-(α,α,α-trifluoro-o-tolyl)propionate
642-974-5
400882-07-7
Carc. 2; Skin Sens. 1A
Details
cyproconazole (ISO); (2RS,3RS;2RS,3SR)-2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl) butan-2-ol
619-020-1
94361-06-5
Repr. 1B; Acute Tox. 3; STOT RE 2
Details
cyprodinil (ISO); 4-cyclopropyl-6-methyl-N-phenylpyrimidin-2-amine
601-785-8
121552-61-2
Skin Sens. 1
Details
demeton
620-378-6
8065-48-3
Acute Tox. 1; Acute Tox. 2
Details
di-L-para-menthene
686-814-2
34363-01-4
Skin Irrit. 2; Skin Sens. 1
Details
Stranica 95 od 99
50 Broj stavki po stranici
Prikaz 4.701 - 4.750 od 4.917 rezultata.

Export search results to: